The 2025 SANS SOC Survey shows AI use is rising, but many SOCs lack integration, customization, and clear validation ...
HONG KONG, Dec. 30, 2025 /PRNewswire/ — Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed ...